Prenatal markers of neonatal fat mass: A systematic review

Jorine A Roelants1, Rogier C J de Jonge1, Régine P M Steegers-Theunissen2

  • 1Department of Pediatrics, Division of Neonatology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands.

Insights

No reliable prenatal markers currently identify fetuses at risk for neonatal adiposity. Further research is needed to find clinically applicable methods for assessing infant body composition during pregnancy.

Area of Science:

  • Perinatal health
  • Neonatal development
  • Maternal-fetal medicine

Background:

  • Prenatal environmental factors can permanently influence offspring phenotype.
  • Identifying fetuses at risk for neonatal adiposity requires clinically applicable markers.
  • Neonatal adiposity has lifelong health implications.

Purpose of the Study:

  • To systematically review existing literature on prenatal markers for neonatal fat mass.
  • To evaluate the clinical applicability of identified prenatal markers for neonatal adiposity risk.

Main Methods:

  • Systematic literature search for original English research papers.
  • Inclusion criteria: dynamic prenatal markers, neonatal fat mass measured within one month post-birth using validated methods (e.g., DXA, MRI).
  • Independent review of study selection, quality assessment (QUADAS-II), and clinical applicability appraisal.

Main Results:

  • 16 studies were included from 2333 initially identified; only 4 were of moderate/high methodological and statistical quality.
  • Investigated prenatal markers included ultrasound parameters, maternal biochemical markers (e.g., BMI, glucose, HbA1c), and maternal characteristics, yielding inconsistent results.
  • Clinical applicability of all assessed markers was rated as poor, precluding meta-analysis due to heterogeneity.

Conclusions:

  • Despite identified associations, no prenatal marker proved sufficiently reliable or clinically applicable for identifying neonatal adiposity risk.
  • Lack of methodological/statistical quality, inconsistent findings, and poor applicability limit current options.
  • No markers were assessed during the periconceptional or embryonic periods, indicating a research gap.
Abstract

Related Concept Videos